ArticleThe Annals of thoracic surgery2020
Effect of Concomitant Tricuspid Valve Surgery With Left Ventricular Assist Device Implantation.
Article in The Annals of thoracic surgery, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.
- Prediction of right ventricular failure after left ventricular assist device implantation in patients with heart failure: a meta-analysis comparing echocardiographic parameters.Interactive cardiovascular and thoracic surgery · 2021Pooled it
- Clinical Implications and Evolution of Significant Tricuspid Regurgitation in Patients Undergoing Left Ventricular Assist Device Implantation.Korean circulation journal · 2026Article
- Early clinical outcomes and quality of life assessment after HeartMate 3 implantation: A single-centre descriptive study.Journal of critical care medicine (Universitatea de Medicina si Farmacie din Targu-Mures) · 2026Article
- Impact of mitral regurgitation reduction on uncorrected tricuspid regurgitation after left ventricular assist device implantation.JTCVS open · 2025Article
- One-stage surgical management for advanced dilated cardiomyopathy combined with aortic sinus aneurysm: a case report.Frontiers in cardiovascular medicine · 2025Article
- How to Select Patients for Left Ventricular Assist Devices? A Guide for Clinical Practice.Journal of clinical medicine · 2023Review
- Managing valvular pathology during LVAD implantation.Indian journal of thoracic and cardiovascular surgery · 2023Article
- Tricuspid regurgitation in the setting of LVAD support.Frontiers in cardiovascular medicine · 2023Review
- Basic pathophysiology and options of treatment for surgical management of functional tricuspid regurgitation: a systematic review.Journal of thoracic disease · 2022Review
- Predicting, Recognizing, and Treating Right Heart Failure in Patients Undergoing Durable LVAD Therapy.Journal of clinical medicine · 2022Review
- Tricuspid surgery at the time of LVAD implant: A critique.Frontiers in cardiovascular medicine · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors at 3 institutions in 1 country.
Funding
Abstract
backgroundTricuspid regurgitation (TR) is common in advanced heart failure (HF) patients. However, the effect of concomitant tricuspid valve repair or replacement (tricuspid valve intervention [TVI]) with left ventricular assist device (LVAD) implantation is controversial. The aim of this study was to investigate the longitudinal trend of TR after LVAD implantation and the effect of TVI on the TR trend and clinical outcomes.
methodsWe retrospectively reviewed patients at our institution who underwent LVAD implantation between April 2014 and August 2018. We evaluated the grade of TR by echocardiography before and after LVAD implantation. Moderate or greater TR was defined as significant.
resultsAmong 199 consecutive patients, 194 had at least 2 echocardiographic TR assessments before and after LVAD implantation. Of these patients, 108 were included in the TVI-positive (TVI+) group and 86 in the TVI-negative (TVI-) group. In the TVI+ group, the prevalence of significant TR decreased from 52% to about 20% in the first 6 months after implantation (P < .01). Overall survival and HF readmission-free survival were comparable between the TVI+ and TVI- patients. In contrast, patients in both groups who had significant postoperative TR during early follow-up had worse 2-year HF readmission-free survival (36% in patients with significant postoperative TR vs 55% in those without significant postoperative TR; P = .028).
conclusionsConcomitant TVI with LVAD implantation improved TR in most patients but did not have an impact on clinical outcomes. Significant postoperative TR after LVAD implantation, in patients with and without TVI, was associated with worse HF-free outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.